BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Farmers Insurance
Queensland Health
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090999

« Back to Dashboard

NDA 090999 describes APREPITANT, which is a drug marketed by Glenmark Pharms Ltd and Sandoz and is included in two NDAs. It is available from two suppliers. Additional details are available on the APREPITANT profile page.

The generic ingredient in APREPITANT is aprepitant. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aprepitant profile page.

Summary for 090999

Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 090999

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
APREPITANT aprepitant CAPSULE;ORAL 090999 ANDA Sandoz Inc 0781-2321 0781-2321-06 1 CAPSULE in 1 CARTON (0781-2321-06)
APREPITANT aprepitant CAPSULE;ORAL 090999 ANDA Sandoz Inc 0781-2321 0781-2321-51 5 CAPSULE in 1 CARTON (0781-2321-51)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength40MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength80MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength125MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: